SCHEMBL367236

SCHEMBL367236

COc1cc(OC(=O)N2CCOCC2)cc2c1c(C(N)=O)c1ccccn12

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
EPHX1 P07099 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
TP53 P04637 1/20 0.44
HSD17B10 Q99714 1/20 0.43
KMT2A Q03164 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
GAA P10253 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MEN1 O00255 2/20 0.42
CASP3 P42574 1/20 0.42
SENP7 Q9BQF6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL366113 0.91 EPHX1 (0.49) TSHRL3MBTL1EPHX1NPC1RAB9A
SCHEMBL365263 0.88 EPHX1 (0.47) TSHREPHX1NPC1RAB9ATP53
SCHEMBL365100 0.82 EPHX1 (0.52) TSHRL3MBTL1EPHX1NPC1RAB9A
SCHEMBL365489 0.81 KMT2A (0.36) RAB9AKMT2AMEN1
SCHEMBL367408 0.79 EPHX1 (0.51) TSHREPHX1NPC1RAB9ATP53
SCHEMBL367759 0.78 STS (0.41) NPC1HSD17B10KMT2AKDM4EGAA
SCHEMBL367237 0.78 TSHR (0.49) TSHRL3MBTL1EPHX1NPC1RAB9A
SCHEMBL366074 0.77 POLB (0.33) NPC1RAB9ATP53KMT2AKDM4E
SCHEMBL365191 0.76 MKNK2 (0.40) NPC1RAB9AKMT2AKDM4EGAA
SCHEMBL367765 0.76 NPC1 (0.43) TSHRNPC1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO claimed
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed